Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID07052916

Pilot Trial of Telehealth Music Therapy for Cognitive Dysfunction in Hematologic Cancer Survivors (PRELUDE)

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-05-26

60

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether telehealth music therapy can be a practical treatment for cognitive difficulties in adults who have survived blood cancers such as lymphoma, leukemia, or myeloma. The study also examines if music therapy and music education can help improve cognitive function as well as symptoms like anxiety, depression, and fatigue in this population. This pilot trial is exploring these effects in hematologic cancer survivors who experience cancer-related cognitive dysfunction. Participants will be assigned to one of three groups: the experimental music therapy (MT) group, the therapist-attention music education (TAME) control group, or a wait-list control (WLC) group receiving usual care. Those in the MT and TAME groups will receive 12 weekly 60-minute sessions, with homework assignments between sessions to reinforce skills and concepts. The WLC group completes assessments during a 24-week wait period and can later choose to receive either the MT or TAME intervention. During the study, participants will complete assessments to measure the feasibility of telehealth music therapy, defined by completing at least 9 of the 12 sessions. Researchers will monitor cognitive function, mood symptoms, and fatigue. Participants must be able to complete study assessments independently and consent in English. The total study duration includes the intervention period and follow-up assessments to evaluate outcomes related to cancer-related cognitive dysfunction.

CONDITIONS

Brief Title

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • English proficient and aged 18 or older
  • Diagnosed with lymphoma, leukemia, or myeloma
  • Stable oncologic disease or no evidence of disease as confirmed by medical chart or oncology team
  • Score of less than 54 on the FACT-Cog PCI subscale
  • Minimum life expectancy of one year as assessed by clinician
  • Able to understand and complete all study assessments independently
  • Able to understand and provide signed informed consent in English
Not Eligible

You will not qualify if you...

  • Less than 3 months since completion of surgery, radiation, induction chemotherapy, transplantation, or immunotherapy
  • On continuous therapy but less than 6 months completed
  • Received music therapy in the past year
  • Current or planned music training exceeding 6 months in the past 10 years
  • No access to an internet-connected device
  • Active suicidal ideation, bipolar disorder, schizophrenia, or substance abuse
  • BOMC score of 10 or higher (indicative of dementia)
  • Uncorrectable visual, auditory, or motor impairments
  • Recent or planned changes in sedative, stimulant, or anti-cholinergic medications
  • Recent or planned interventions for cancer-related cognitive dysfunction within the past month or during the study period

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility assessment

Treatment

Duration - Approximately 12 weeks

Participants receive weekly 60-minute music therapy sessions or therapist-attention music education sessions for cognitive difficulties, with homework assignments between sessions to reinforce skills and concepts.

12 weekly sessions (remote via telehealth)

Follow-up

Duration - Up to 1 year

Participants complete assessments to evaluate the feasibility and effects of the intervention after the treatment period.

Periodic assessments as scheduled by the study team

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering Basking Ridge (All protocol activities)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (All protocol activities)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (All protocol activities)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (All protocol activities)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center (All protocol activities)

New York, New York, United States, 10065

Actively Recruiting

7

Memorial Sloan Kettering Nassau (All protocol activities)

Uniondale, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

K

Kevin Liou, MD

J

Jun Mao, MD, MSCE

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

Use of [F-18] FLT for Imaging With Positron Emission Tomogra...

Brain and Central Nervous System Tumors

Actively Recruiting

1 location

Targeting Measurable Residual Disease in Acute Myeloid Leuke...

Acute Myeloid Leukaemia (AML)

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here